REYON Pharmaceutical Co., Ltd. (KRX:102460)
11,360
+100 (0.89%)
Dec 19, 2025, 3:30 PM KST
REYON Pharmaceutical Market Cap
REYON Pharmaceutical has a market cap or net worth of 208.35 billion as of December 19, 2025. Its market cap has decreased by -20.61% in one year.
Market Cap
208.35B
Enterprise Value
414.05B
Revenue
149.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,360.00
Market Cap Chart
Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 208.35B, an increase of 26.62%. That is a compound annual growth rate of 1.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 208.35B | -11.53% |
| Dec 30, 2024 | 235.50B | -22.37% |
| Dec 28, 2023 | 303.36B | -21.07% |
| Dec 29, 2022 | 384.35B | -39.10% |
| Dec 30, 2021 | 631.11B | 61.64% |
| Dec 30, 2020 | 390.43B | 47.64% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.45T |
| Celltrion | 39.93T |
| ALTEOGEN | 23.05T |
| SK Biopharmaceuticals | 10.26T |
| ABL Bio | 10.04T |
| Yuhan | 8.52T |
| LigaChem Biosciences | 6.14T |
| HLB Co., Ltd. | 6.05T |